| Literature DB >> 27213184 |
Veronica Balatti1, Mario Acunzo1, Yuri Pekarky1, Carlo M Croce1.
Abstract
B-cell chronic lymphocytic leukemia (CLL) is the most common adult human leukemia. Although, the molecular alterations leading to CLL onset and progression are still under investigation (specifically, the interplay and exact role of oncogenes and tumor suppressors in CLL pathogenesis). MicroRNAs are small non-coding RNAs that regulate gene expression and are expressed in a tissue specific manner. Deregulation of microRNAs can alter expression levels of genes involved in the development and/or progression of tumors. In CLL, microRNAs can function as oncogenes or tumor suppressors. Here, we review the most recent findings on the role of microRNAs in the onset/progression of CLL, and how this knowledge can be used to identify new biomarkers and targets to treat this leukemia.Entities:
Keywords: CLL; miR-15/16; microRNA
Year: 2016 PMID: 27213184 PMCID: PMC4874335 DOI: 10.1016/j.trecan.2016.02.005
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025